Cure diseases through next generation 4D tissue bioprinting

publicado: 23 mar 2022  |  
No s'ha trobat cap mèdia.
Comentarios (0)
  • Creatio, the Center for the Production and Validation of Advanced Therapies at the University of Barcelona (UB), ​​has obtained funding of almost one million euros from the Spanish Ministry of Science and Innovation to acquire and set up one of the first GMP-qualified 4D bio-printers in the world.

    The director of Creatio, Dr. Josep M. Canals, and the University’s Dean, Dr. Joan Guàrdia, explain the importance of this acquisition for the development of innovative cell treatments for incurable diseases such as neurodegenerative disorders. With this acquisition, Creatio places itself at the forefront of translational research in tissue engineering.

    Llicència Creative Commons by-nc-nd
    Alerta de contenido erróneoCerrar
    Si heu detectat algún error a aquest vídeo ens ho podeu notificar al correu mencionant l'identificador del vídeo: 117254
    ©Universitat de Barcelona
  • Subtítulos  Sin Subtítulos  Inglés  
  • Codi per incrustar aquest vídeo
  • Para descargar los ficheros haz clic en "Botón derecho" sobre el enlace y "Guardar enlace como".
    Subtítulos: Inglés (.srt)